Lavino Francesco Maria 4/A
4/A · Nabriva Therapeutics plc · Filed Aug 26, 2019
Insider Transaction Report
Form 4/AAmended
Lavino Francesco Maria
Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2019-08-21$2.08/sh−3,797$7,898→ 11,172 total
Footnotes (1)
- [F1]This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019.